BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sguizzato M, Esposito E, Cortesi R. Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier. Int J Mol Sci 2021;22:8319. [PMID: 34361084 DOI: 10.3390/ijms22158319] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen T, Duong V. Solid Lipid Nanoparticles. Encyclopedia 2022;2:952-73. [DOI: 10.3390/encyclopedia2020063] [Reference Citation Analysis]
2 Wertz PW. Synopsis of Barrier Function of Skin and Oral Mucosa-Volume 1. Int J Mol Sci 2021;22:9383. [PMID: 34502292 DOI: 10.3390/ijms22179383] [Reference Citation Analysis]
3 Mehanna MM, Abla KK, Domiati S, Elmaradny H. Superiority of Microemulsion-based Hydrogel for Non-Steroidal Anti-Inflammatory Drug Transdermal Delivery: A Comparative Safety and Anti-nociceptive Efficacy Study. Int J Pharm 2022;:121830. [PMID: 35589005 DOI: 10.1016/j.ijpharm.2022.121830] [Reference Citation Analysis]
4 Stefanov SR, Andonova VY. Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders. Pharmaceuticals (Basel) 2021;14:1083. [PMID: 34832865 DOI: 10.3390/ph14111083] [Reference Citation Analysis]
5 Gomes A, Aguiar L, Ferraz R, Teixeira C, Gomes P. The Emerging Role of Ionic Liquid-Based Approaches for Enhanced Skin Permeation of Bioactive Molecules: A Snapshot of the Past Couple of Years. Int J Mol Sci 2021;22:11991. [PMID: 34769430 DOI: 10.3390/ijms222111991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rincón M, Silva-Abreu M, Espinoza LC, Sosa L, Calpena AC, Rodríguez-Lagunas MJ, Colom H. Enhanced Transdermal Delivery of Pranoprofen Using a Thermo-Reversible Hydrogel Loaded with Lipid Nanocarriers for the Treatment of Local Inflammation. Pharmaceuticals (Basel) 2021;15:22. [PMID: 35056079 DOI: 10.3390/ph15010022] [Reference Citation Analysis]
7 Kandregula B, Narisepalli S, Chitkara D, Mittal A. Exploration of Lipid-Based Nanocarriers as Drug Delivery Systems in Diabetic Foot Ulcer. Mol Pharm 2022. [PMID: 35481377 DOI: 10.1021/acs.molpharmaceut.1c00970] [Reference Citation Analysis]